Intravaginal misoprostol as a cervical ripening agent

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine

Background:

• Cervical ripening is crucial for labor induction when delivery is indicated.
• Unripe cervices can prolong gestation and necessitate interventions.

Purpose of the Study:

• To evaluate the efficacy of intravaginal misoprostol (exogenous prostaglandin E1) in improving Bishop score.
• To determine if misoprostol facilitates early, safe vaginal delivery in women with unripe cervices.

Main Methods:

• A double-blind, randomized clinical trial involving 45 women with indications for labor induction.
• Women received either 100 micrograms of intravaginal misoprostol or a placebo.
• Efficacy was assessed by changes in Bishop score, time to delivery, oxytocin requirement, and pregnancy outcomes.

Main Results:

• Misoprostol significantly improved Bishop scores (5.3 vs. 1.5, P < 0.001) and reduced time to delivery (15.6 vs. 43.2 hours, P < 0.001).
• Oxytocin requirement was lower in the misoprostol group (29% vs. 62%, P < 0.02).
• No significant differences in delivery complications, Apgar scores, or mode of delivery were observed.

Conclusions:

• Intravaginal misoprostol is a highly effective method for cervical ripening and labor induction.
• It offers a safe, cost-effective approach to initiating labor in the third trimester.